USPTO 2015–2025 USPTO PatentsView US Corporation

Bigfoot Biomedical, Inc.

USPTO PatentsView assignee record — 160 granted patents across 21 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR).

160
Total patents granted
21
CPC technology areas
18.5
Avg claims per patent
+32%
5-year filing velocity

The verdict

Bigfoot holds 160 US patents across 21 technology areas — rank #2,432 of 50,000 tracked assignees.

#2,432
of 50,000 US assignees by volume
Top 17%
by Innovation Score (48.3/100)
18.5
avg claims per patent
+32%
filing velocity, last 5 yrs

Portfolio overview

Bigfoot Biomedical, Inc. has been granted 160 US utility patents between 2015 and 2025, placing Bigfoot Biomedical, Inc. at rank #2,432 across all assignees tracked by PlainPatent. This portfolio spans 21 distinct Cooperative Patent Classification (CPC) subclasses, averaging 18.5 claims per patent with primary concentration in A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR). As a US Corporation, Bigfoot Biomedical, Inc. is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 48.3/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 91 grants, compared with 69 in the 2015–2019 window — a +32% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Bigfoot Biomedical, Inc.'s 18.5 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 21 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Bigfoot Biomedical, Inc. against peers pursuing similar technology classes.

How does Bigfoot compare?

Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀

patents

What this shows Bigfoot holds 160 patents — placing it at rank #2,432 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.

Source USPTO PatentsView — granted utility patents As of 2015–2025

Bigfoot's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

48 Top 17% higher than 83% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). Below this entry. 30–40: 15,294 US assignees (31%). Below this entry. 40–50: 11,491 US assignees (23%). This entry sits in this band. 50–60: 5,058 US assignees (10%). Above this entry. 60–70: 1,537 US assignees (3%). Above this entry. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView — PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

051015202530 20152016201720182019202020212022202320242025 9
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Bigfoot Biomedical, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 5 3.1%
2016 19 11.9%
2017 12 7.5%
2018 15 9.4%
2019 18 11.3%
2020 21 13.1%
2021 27 16.9%
2022 15 9.4%
2023 8 5.0%
2024 11 6.9%
2025 9 5.6%

Which technologies does Bigfoot Biomedical, Inc. patent most?

Top 15 of 21 technology areas

Patent Moat Analysis

Portfolio Volume Moderate
Tech Breadth Multi-domain
Claim Depth Standard
Velocity Growing

Where it ranks

Overall rank by patents

#2,432

Across all tracked assignees

Innovation Score

48.3 out of 100

View all rankings →

Data Source

USPTO PatentsView — US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Bigfoot Biomedical, Inc. hold?
Bigfoot Biomedical, Inc. holds 160 US granted patents filed between 2015 and 2025, spanning 21 technology areas.
What is Bigfoot Biomedical, Inc.'s Innovation Score?
Bigfoot Biomedical, Inc. has an Innovation Score of 48.3 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Bigfoot Biomedical, Inc. focus on?
Bigfoot Biomedical, Inc.'s top technology area is A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR) with 143 patents. The company has filed patents in 21 CPC subclasses total.
Is Bigfoot Biomedical, Inc.'s patent filing rate increasing or decreasing?
Bigfoot Biomedical, Inc.'s recent filing velocity is +32% compared to the prior five-year period. The company is maintaining or growing its patent output.
What does claim depth mean for Bigfoot Biomedical, Inc.'s patents?
Bigfoot Biomedical, Inc.'s patents average 18.5 claims each. This falls within the standard range, providing solid legal coverage.
How is the Bigfoot Biomedical, Inc. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

Learn More

Explore the patent dataset

Data sourced from USPTO PatentsView — official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

All federal data sources used on this page
  • USPTO PatentsView — official U.S. Patent and Trademark Office bulk patent data. patentsview.org
  • USPTO Patent Application Information Retrieval (PAIR) — application status and file history. uspto.gov/patents/pair
  • USPTO Bulk Data Storage System — comprehensive patent text + claims dataset. bulkdata.uspto.gov
  • USPTO CPC Classification — Cooperative Patent Classification scheme for technology categorization. uspto.gov/cpc
  • SEC EDGAR — public filings cross-reference for assignee corporate entity matching. sec.gov/edgar
  • WIPO PATENTSCOPE — international patent context (related international filings). wipo.int/patentscope